-
The appropriateness of statin therapy for persons with hyperlipidemia is well established. Although clinical trial data showing reductions in cardiovascular events with statin therapy are consistent and impressive, patients treated outside of clinical trial settings may have obstacles to enjoying the same benefits.
-
Endometrial cancer is the most common gynecologic malignancy and is usually characterized by limited disease at presentation. Among the number of known prognostic factors, grade of disease is one frequently used to triage patients for formal surgical staging.
-
Souka and colleagues have recently published a review that should be very helpful to the clinician confronted with the dilemma of counseling patients whose fetuses have increased nuchal translucencies (NTs) in the first trimester.
-
Erectile Dysfunction and Visual Disturbance; Mixed News on Statins; FDA Actions
-
A study that attracted some attention at the Society for Maternal-Fetal Medicine meeting last year was recently published in the American Journal of Obstetrics and Gynecology. It dealt with the usefulness of fetal fibronectin (fFN) and cervical length (CL) in predicting which patients with preterm contractions (PTC) were truly in preterm labor (PTL).
-
Epidemiologists at the National Cancer Institute organized and conducted a retrospective cohort study, recruiting patients treated between 1965 and 1988 from endocrine and infertility practices in 5 academic centers.
-
-
Is your family planning facility seeing more women who are HIV-positive? Statistics point to a yes. In 2003, women accounted for 27% of the estimated 32,048 diagnoses of HIV infection in the United States, according to statistics from the Atlanta-based Divisions of HIV/AIDS Prevention of the Centers for Disease Control and Prevention (CDC).
-
When discussing sexually transmitted diseases (STDs) with your patients, what do you tell them about human papillomavirus (HPV)? Exposure to HPV can have significant health implications, particularly for women. Some strains of the virus, including HPV-16 and HPV-18, can trigger cancers of the cervix.
-
The options in barrier contraceptives for American women have been reduced as the sole U.S. company distributing the Prentif Cavity-Rim Cervical Cap has announced its dissolution and the device is no longer available in the United States.
